An Endogenously Gated DNA Nanodevice Enables Mitochondria-Specific FEN1 Monitoring in Response to Therapeutic Challenge.

Authors

Lie Li, Baozhu Hu, Chang Liu, Yu Wang, Bin Ning, Xuerui Zhang, Jin Jiao

Published in

ACS sensors. Nov 06, 2026. Epub Nov 06, 2026.

Abstract

Monitoring therapy-induced molecular changes within subcellular compartments is crucial for understanding cellular stress and providing clues to treatment response. Mitochondrial base excision repair (BER) enzymes have emerged as promising indicators of therapeutic response, yet effective tools for their on-site and dynamic monitoring remain scarce. Here, we report an endogenously gated DNA nanodevice (EGDN) capable of real-time, mitochondria-specific monitoring of flap endonuclease 1 (FEN1), a key BER enzyme, under therapeutic challenge. The EGDN remains silent during transport and is sequentially activated by the mitochondria-encoded ribosomal RNA and FEN1, thus achieving spatial control over FEN1 imaging. This conditional regulation pattern reduces nonspecific signals and sharpens the spatial resolution of FEN1 visualization within mitochondria. We further demonstrate that EGDN dynamically tracks mitochondrial FEN1 fluctuations in tumor cells undergoing chemotherapy or radiation therapy, providing a molecular readout of treatment-associated alterations. Collectively, this work establishes a robust biosensing toolbox for dissecting the BER process at the subcellular level, with broad implications for cancer early diagnosis and targeted therapy.

PMID:
42993672
Bibliographic data and abstract were imported from PubMed on 07 Nov 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.